Robert Lenz

Amgen Inc - Thousand Oaks / United States

Natural Sciences / Biological Science

AD Scientific Index ID: 4425031

-

Registration, Add Profile,
Premium Membership

Print Your Certificate

Robert Lenz's MOST POPULAR ARTICLES

1-) A controlled trial of erenumab for episodic migrainePJ Goadsby, U Reuter, Y Hallström, G Broessner, JH Bonner, F Zhang, ...New England Journal of Medicine 377 (22), 2123-2132, 20177282017

2-) Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trialS Tepper, M Ashina, U Reuter, JL Brandes, D Doležil, S Silberstein, ...The Lancet Neurology 16 (6), 425-434, 20176152017

3-) Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson\\\\\\\'s disease: a randomised, controlled, double-blind, double-dummy studyCW Olanow, K Kieburtz, P Odin, AJ Espay, DG Standaert, HH Fernandez, ...The Lancet Neurology 13 (2), 141-149, 20146082014

4-) ARISE: a phase 3 randomized trial of erenumab for episodic migraineDW Dodick, M Ashina, JL Brandes, D Kudrow, M Lanteri-Minet, V Osipova, ...Cephalalgia 38 (6), 1026-1037, 20186202018

5-) Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trialH Sun, DW Dodick, S Silberstein, PJ Goadsby, U Reuter, M Ashina, ...The Lancet Neurology 15 (4), 382-390, 20164202016

ARTICLES

Add your articles